First Opinion Podcast

STAT

A weekly podcast about the people, issues and ideas that are shaping health care.

  1. 17/12/2025

    Francis Collins and Marc Siegel say medicine is a gift from God

    Religion and science can often seem in opposition, at least culturally. But they don’t have to be, say Marc Siegel and Francis Collins. Siegel, who is a physician and a senior medical analyst at Fox News, has recently published a new book, “The Miracles Among Us: How God's Grace Plays a Role in Healing,” in which he tells stories of unexpected — miraculous, he says —recoveries. On this episode of the “First Opinion Podcast,” host Torie Bosch speaks with Siegel and Francis Collins — former director of the National Institutes of Health and the author of “The Language of God: A Scientist Presents Evidence for Belief.” They discuss the intersection of faith and science, particularly the ways that some Christian communities have increasingly become skeptical of medicine like vaccines.

    42 min

  2. 10/12/2025

    The revolution in dementia care is just beginning

    When Jason Karlawish started working with dementia patients in the late ’90s, there often wasn’t much he could offer them. “I gave them a diagnosis,” he told me on this week’s episode of the “First Opinion Podcast,” but had limited medications to prescribe. Now Karlawish — who is STAT’s Neurotransmissions columnist; a professor of medicine, medical ethics, health policy, and neurology at the University of Pennsylvania; co-director of the Penn Memory Center; and executive producer of the “Age of Aging” podcast — says a revolution is taking place in dementia care, thanks to diagnostics that are removing uncertainty and treatments that actually have some effect.

    40 min

  3. 03/12/2025

    ‘Where’s our CRISPR miracle?’

    Celena Lozano's son Benny, who turned 5 in November, loves trains, trucks — anything that goes. He also has a rare disease, PURA syndrome. Earlier this year, when headlines announced that a child with a different rare disease, known as Baby KJ, had been treated using CRISPR in a major breakthrough, Celena, a neuroscience Ph.D. candidate, found that many in the PURA community had major questions, with comments like “This happened in just six months. When will this be available for our PURA kids?” appearing on Facebook groups. Celena and STAT reporter Jason Mast joined the podcast to discuss why CRISPR for PURA syndrome is particularly difficult, what it’s like to be both a rare disease parent and a scientist, and how crucial parents are to research.

    30 min

  4. 26/11/2025

    Why beagles are the No. 1 dog for medical research

    As science journalist Melanie D.G. Kaplan describes in her new book, “Lab Dog,” tens of thousands of beagles are used in the U.S. for medical research, testing chemical safety, and more. In “Lab Dog,” Melanie goes on a journey with her beloved adopted beagles, Hammy, a retired research dog, to find out where he came from. Along the way, she explores the ways that dogs contribute to medical research, the potential and limitations of substitutes for animals in the lab. In this episode, we discuss the ethics of animal research, Hammy’s story, the U.S. government’s attempt to move away from animal research, and why the number of beagles used in lab research has dropped from 70,000 when she adopted Hammy to 40,000 today.

    27 min

  5. 19/11/2025

    Fighting anti-vax bills in a red state — and winning

    In the wake of the pandemic, North Dakota, like many states, suddenly saw a splintering of opinion around vaccines. “Not only was I concerned about the decline of vaccinations, but I was even more concerned about the fabric of communities,” Sandy Tibke, executive director of the Foundation for a Healthy North Dakota, said on the this week’s podcast. So she teamed up with Josh Gryniewicz of Odd Duck, a communications consultancy. Together, they crisscrossed North Dakota, hosting listening sessions on health-related topics that went well beyond vaccines. On this episode of the “First Opinion Podcast,” host Torie Bosch spoke with Sandy and Josh about their work and the lessons it offers others in public health.

    43 min

  6. 12/11/2025

    James Watson’s lifelong friend and protégé on his complicated legacy

    James Watson, who won the Nobel Prize for co-discovering the structure of DNA, died last week at the age of 97. He was a scientific giant, but in the final two decades of his life, he falsely stated that women and Black people are, as populations, not as smart as white men. Nancy Hopkins knew Watson better than most, having first worked with him when she was just an undergraduate. She is a retired MIT professor known for her work on zebrafish as a cancer model, and for her advocacy on behalf of women in science. Today, she is trying to reconcile her “lifelong friend,” the Watson one who encouraged her and other women to go into molecular biology, with the one who emerged late in life.

    37 min

  7. 05/11/2025

    Is it ever OK for doctors to ‘fake’ CPR?

    On TV, CPR looks like a miracle: a few light pushes on the chest, a couple of assisted breaths, and the person sputters back to life. “CPR has been represented in the media and TV shows and all of these other places as a relatively innocuous intervention with high rates of success from which people recover with little problem,” Jason Wasserman said on this episode of the “First Opinion Podcast.” In fact, it can be physically damaging—broken ribs, punctured lungs — and painful. And for patients who are already medically frail, it often fails. So sometimes, particularly with patients clearly at the end of life, doctors might do something that isn’t often discussed outside of medical circles: the slow code. That’s when they intentionally move slowly, or don’t put as much effort into CPR as would be necessary to revive someone. On this episode of the podcast, guest host Alex Hogan spoke with Wasserman and Parker Crutchfield about a recent special issue of the journal Bioethics that they edited on the slow code and a related op-ed they wrote for First Opinion. They discussed the ethical conundrum of the slow code, the response to their work from medical professionals, and why it’s particularly important to have this discussion now. “Beyond the physical or material harms that can be associated with CPR,” Wasserman said, “we can think about what we might call dignitary harms, just harms of disrespect to the person and to the body. And I think these are especially poignant when we’re talking about futile or medically inappropriate CPR that we’re doing.” Their conversation was also based on a recent episode of the new video series “STATus Report.” Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. And don’t forget to sign up for the First Opinion newsletter, delivered every Sunday.

    29 min

  8. 29/10/2025

    A ‘devil’s choice’ on vaccines and pandemic preparedness

    Vaccine hesitancy isn’t new, Seth Berkley points out. “The first vaccine was smallpox vaccine,” he said on this week’s episode of the “First Opinion Podcast,” “and right after they were first used, there were wood cuttings of people with cows’ horns growing out of their heads because the virus was isolated from cows.” Berkley is the former head of Gavi, the Vaccine Alliance, a co-founder of COVAX, and author of the new book “Fair Doses: An Insider’s Story of the Pandemic and the Global Fight for Vaccine Equity.” On this episode of the podcast, we discussed what went right and wrong with the response to Covid — and preparing for the next pandemic.

    30 min
Ver todo (153)

Tráiler

Acerca de

A weekly podcast about the people, issues and ideas that are shaping health care.

Información

  • Canal
    STAT
  • Creador
    STAT
  • Años de actividad
    2021 - 2025
  • Episodios
    153
  • Clasificación
    Apto
  • Copyright
    © All rights reserved
  • Mostrar sitio web
    First Opinion Podcast

Más de STAT

También te podría interesar